Lv12
46 积分 2021-03-15 加入
Continuous Toxicity Monitoring in Phase II Trials in Oncology
4小时前
已关闭
Advanced multiplicity adjustment methods in clinical trials
1天前
已完结
Efficacy and safety of sovleplenib (HMPL-523) in adult patients with chronic primary immune thrombocytopenia in China (ESLIM-01): a randomised, double-blind, placebo-controlled, phase 3 study
8天前
已完结
Efficacy and safety of sovleplenib (HMPL-523) in adult patients with chronic primary immune thrombocytopenia in China (ESLIM-01): a randomised, double-blind, placebo-controlled, phase 3 study
8天前
已完结
Incomparability of treatment groups is often blindly ignored in randomised controlled trials – a post hoc analysis of baseline characteristic tables
13天前
已完结
Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project
15天前
已完结
BCMA-Targeted T-Cell Engager for Autoimmune Hemolytic Anemia after CD19 CAR T-Cell Therapy
15天前
已完结
Safety and efficacy of astegolimab for COPD with frequent exacerbations regardless of baseline blood eosinophil counts (ALIENTO and ARNASA): randomised, double-blind, placebo-controlled, phase 2b and 3 trials
2个月前
已完结
Safety and efficacy of astegolimab for COPD with frequent exacerbations regardless of baseline blood eosinophil counts (ALIENTO and ARNASA): randomised, double-blind, placebo-controlled, phase 2b and 3 trials
2个月前
已完结
Comparative Efficacy of Seven Biologics for Chronic Rhinosinusitis With Nasal Polyps: A Network Meta‐Analysis
3个月前
已完结
皖公网安备34019202002308
